Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Leukemia and CYP3A[original query] |
---|
Polymorphism analysis of CYP3A5 in myeloid leukemia. Oncology reports 0 9 (2): 327-9. Liu Ta-Chih, Lin Sheng-Fung, Chen Tyen-Po, Chang Jan-Gow |
Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies. Pharmacogenetics 2002 Nov 12 (8): 605-11. Blanco Javier G, Edick Mathew J, Hancock Michael L, Winick Naomi J, Dervieux Thierry, Amylon Michael D, Bash Robert O, Behm Frederick G, Camitta Bruce M, Pui Ching-Hon, Raimondi Susana C, Relling Mary |
Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia. Blood 2004 Jan 103 (1): 67-72. Kishi Shinji, Yang Wenjian, Boureau Benoit, Morand Stanislas, Das Soma, Chen Peixian, Cook Edwin H, Rosner Gary L, Schuetz Erin, Pui Ching-Hon, Relling Mary |
Genetic polymorphism of CYP3A5 in Indian chronic myeloid leukemia patients. Molecular and cellular biochemistry 2010 Mar 336 (1-2): 49-54. Bajpai Prachi, Tripathi Anil Kumar, Agrawal Dee |
Analysis of CYP3A5*3 and CYP3A5*6 gene polymorphisms in Indian chronic myeloid leukemia patients. Asian Pacific journal of cancer prevention : APJCP 2010 11 (3): 781-4. Sailaja K, Rao D Nageswara, Rao D Raghunadha, Vishnupriya |
Association of CYP3A5*3 polymorphism with development of acute leukemia. Indian journal of human genetics 2011 Sep 17 (3): 175-8. Rao D Nageswara, Manjula G, Sailaja K, Surekha D, Raghunadharao D, Rajappa Senthil, Vishnupriya |
Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer. Cancer research 2016 Mar 76 (6): 1485-93. Johnson Nichola, De Ieso Paolo, Migliorini Gabriele, Orr Nick, Broderick Peter, Catovsky Daniel, Matakidou Athena, Eisen Timothy, Goldsmith Christy, Dudbridge Frank, Peto Julian, Dos-Santos-Silva Isabel, Ashworth Alan, Ross Gillian, Houlston Richard S, Fletcher Oliv |
Effects of cytochrome P450 family 3 subfamily A member 5 gene polymorphisms on daunorubicin metabolism and adverse reactions in patients with acute leukemia. Molecular medicine reports 2017 Apr . Huang Zhen, Wang Juxiang, Qian Jiangchao, Li Yuan, Xu Zhisheng, Chen Min, Tong Hongf |
Population Pharmacokinetic Analysis of Quizartinib in Healthy Volunteers and Patients With Relapsed/Refractory Acute Myeloid Leukemia. Journal of clinical pharmacology 2020 6 60 (12): 1629-1641. Kang Dongwoo, Ludwig Elizabeth, Jaworowicz David, Huang Hannah, Fiedler-Kelly Jill, Cortes Jorge, Ganguly Siddhartha, Khaled Samer, Krämer Alwin, Levis Mark, Martinelli Giovanni, Perl Alexander, Russell Nigel, Abutarif Malaz, Choi Youngsook, Mendell Jeanne, Yin Ophel |
Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor. Clinical pharmacokinetics 2020 4 59 (10): 1273-1290. James Angela Joubert, Smith Catherine C, Litzow Mark, Perl Alexander E, Altman Jessica K, Shepard Dale, Kadokura Takeshi, Souda Kinya, Patton Melanie, Lu Zheng, Liu Chaofeng, Moy Selina, Levis Mark J, Bahceci Erk |
Development of Physiology Based Pharmacokinetic Model to Predict the Drug Interactions of Voriconazole and Venetoclax. Pharmaceutical research 2022 Jun . Dong Ji, Liu Shuai-Bing, Rasheduzzaman Jony Md, Huang Chen-Rong, Miao Li-Y |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: